Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Ratio Therapeutics Scores $50M Series B

2024-01-17
BOSTON, MA, Ratio Therapeutics announces the close of its $50M Series B financing.
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of cancers, announces the close of its $50M Series B financing, bringing the total raised to date to over $90 million.

The latest round witnessed continued participation from Series A leads Schusterman and Duquesne and welcomed among others PagsGroup, Bristol Myers Squibb and the Center for Technology Licensing at Cornell University.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors